Hellenic Institute For The Study Of Sepsis
Clinical trials sponsored by Hellenic Institute For The Study Of Sepsis, explained in plain language.
-
New drug aims to tame overactive immune response in sepsis
Disease control OngoingThis phase 2 trial tests emapalumab, a drug that blocks a protein called interferon-gamma, in 75 adults with sepsis caused by a specific immune overreaction. The goal is to see if the drug can reduce organ failure, measured by a drop in the SOFA score. Participants are in ICUs ac…
Phase: PHASE2 • Sponsor: Hellenic Institute for the Study of Sepsis • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New test combo could slash unnecessary antibiotic use in sepsis
Knowledge-focused OngoingThis study tests whether using rapid, advanced lab tests to identify the exact bacteria causing a severe infection can help doctors choose the right antibiotics faster. About 190 adults with sepsis in Greek ICUs will either get standard care or the new testing strategy. The goal …
Phase: PHASE3 • Sponsor: Hellenic Institute for the Study of Sepsis • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC